P338
Statin treatment reduces matrix degradation capacity of proinflammatory polarized macrophages

Cardiovascular Research

23 April 2018

Organised by:

Read full article

Contributors

P J Hohensinner

P J Hohensinner

Author

B Thaler

B Thaler

Author

B Ebenbauer

B Ebenbauer

Author

K Huber

K Huber

Author

J Wojta

J Wojta

Author

You may be interested in

Congress Presentation

Statin treatment reduces matrix degradation capacity of proinflammatory polarized macrophages

21 April 2018

Congress Presentation

Cyclodextrin-loaded nanobubbles reduce cholesterol and atherosclerosis in vivo

27 August 2023

Congress Presentation

Cardioprotective cytokine interleukin-33 is upregulated by statins and bisphosphonates in human cardiac cells

20 April 2018

Congress Presentation

The AT1R/NADPH oxidases/SGLT2 pathway plays a key role in mediating lipopolysaccharide-induced macrophage M1 polarization: Protective effect of SGLT2 inhibition

31 August 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources